Drug ApprovalsFDA approves hepatitis B drug that lets some patients stop pills
Hibsago, an antisense injection from GSK, gave about one in five eligible adults a functional cure in two phase 3 trials, against none on placebo.
20 October 2026
Tag
antisense
Drug Approvals
Rare DiseasesGene-silencing drug works in rare ALS that strikes young people
Ionis and Otsuka say ulefnersen improved survival and function in the phase 3 FUSION trial in FUS-ALS, an aggressive genetic motor neurone disease often seen in teenagers.
22 September 2026